Hepatic mechanisms of the Walnut antidiabetic effect in mice

Central European Journal of Biology

Volumn 5, Issue 3, 2010, Pages 304-309

  Kamyab, Hanieh ^a   Hejrati, Shohreh ^a   Khanavi, Mahnaz ^a   Malihi, Farshad ^a   Mohammadirad, Azadeh ^a   Baeeri, Maryam ^a   Esmaily, Hadi ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Gluconeogenesis; Glucose; Glycogenolysis; Leaf; Ridge; Walnut

Indexed keywords

ANIMALIA; JUGLANS; JUGLANS REGIA; MUS;

EID: 77952073357     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-010-0019-z     Document Type: Article

References (45)

1. Rahimi R., Nikfar S., Larijani B., Abdollahi M., A review on the role of antioxidants in the management of diabetes and its complications, Biomed. Pharmacother., 2005, 59, 365-373.
2. Dehghan G., Shafiee A., Ghahremani M. H., Ardestani S. K., Abdollahi M., Antioxidant potential of various extracts from ferula szovitsiana in relation to their phenolic content, Pharm. Biol., 2007, 45, 691-699.
3. Hasani-Ranjbar S., Larijani B., Abdollahi M., A systematic review of Iranian medicinal plants useful in diabetes mellitus, Arch. Med. Sci., 2008, 4, 285-292.
4. Basiri S., Esmaily H., Vosough-Ghanbari S., Mohammadirad A., Yasa N., Abdollahi M., Improvement by satureja khuzestanica essential oil of malathion-induced red blood cells acetylcholinesterase inhibition and altered hepatic mitochondrial glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities, Pestic. Biochem. Physiol., 2007, 89, 124-129.
5. Sarkhail P., Rahmanipour S., Fadyevatan S., Mohammadirad A., Dehghan G., Amin G., et al., Antidiabetic effect of phlomis anisodonta: Effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes, Pharmacol. Res., 2007, 56, 261-266.
6. Malihi F., Hosseini-Tabatabaei A., Esmaily H., Khorasani R., Baeeri M., Abdollahi M., Improvement of inflammatory and toxic stress biomarkers by silymarin in a murine model of type one diabetes mellitus, Cent. Eur. J. Biol., 2009, 4, 1-12.
7. Saadat M., Pournourmohammadi S., Donyavi M., Khorasani R., Amin G., Salehnia A. N., et al., Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by satureja khuzestanica jamzad essential oil, J. Pharm. Pharm. Sci., 2004, 7, 310-314.
8. Mehdipour S., Yasa N., Dehghan G., Khorasani R., Mohammadirad A., Rahimi R., et al., Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to α-tocopherol, Phytother. Res., 2006, 20, 591-594.
9. Hasani-Ranjbar S., Nayebi N., Larijani B., Abdollahi M., A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity, World J. Gastroenterol., 2009, 15, 3073-3085.
10. Hasani-Ranjbar S., Larijani B., Abdollahi M., A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases, Inflamm. Allergy Drug Targets, 2009, 8, 2-10.
11. Kajbaf F., Mojtahedzadeh M., Abdollahi M., Mechanisms underlying stress-induced hyperglycemia in critically ill patients, Therapy, 2007, 4, 97-106.
12. Teimouri F., Amirkabirian N., Esmaily H., Mohammadirad A., Aliahmadi A., Abdollahi M., Alteration of hepatic cells glucose metabolism as a non-cholinergic detoxication mechanism in counteracting diazinon-induced oxidative stress, Hum. Exp. Toxicol., 2006, 25, 697-703.
13. Perry L. M., Medicinal Plants of East and Southeast Asia, MIT Press, Cambridge, 1980.
14. Duke J. A., Handbook of Nuts, CRC Press, London, 1989.
15. Kagawa Y., Standard Tables of Food Composition in Japan, Kagawa Nutrition University Press, Tokyo, 2001.
16. Fukuda T., Ito H., Yoshida T., Effect of the walnut polyphenol fraction on oxidative stress in type 2 diabetes mice, BioFactors, 2004, 21, 251-253.
17. Pereira J. A., Oliveira I., Sousa A., Valentao P., Andrade P. B., Ferreira I. C. F. R., et al., Walnut (Juglans regia L.) leaves: Phenolic compounds, antibacterial activity and antioxidant potential of different cultivars, Food Chem. Toxicol., 2007, 45, 2287-2295.
18. Asgary S., Parkhideh S., Solhpour A., Madani H., Mahzouni P., Rahimi P., Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats, J. Med. Food., 2008, 11, 533-538.
19. Dzhafarova R. E., Garaev G. Sh., Dzhafarkulieva Z. S., Antidiabetic action of extract of Juglans regia L., Georgian Med. News., 2009, 170, 110-114.
20. Hosseini S., Esmaily H., Mohammadirad A., Abdollahi M., Effects of sildenafil a phosphodiesterase 5 inhibitor on rat liver cell key enzymes of gloconeogenesis and glycogenolysis, Int. J. Pharmacol., 2006, 2, 280-285.
21. Chang H. C., Lane M. D., The enzymatic carboxylation of phosphoenolpyruvate. II. Purification and properties of liver mitochondrial phosphoenolpyruvate carboxykinase, J. Biol. Chem., 1966, 241, 2413-2420.
22. Lowry O. H., Schulz D. W., Passonneau J. V., The kinetics of glycogen phosphorylases from brain and muscle, J. Biol. Chem., 1967, 242, 271-280.
23. Lowry O. H., Roserbrough N. J., Farr A. L., Randell R. J., Protein measurement with the folin phenol reagent, J. Biol. Chem., 1951, 193, 265-275.
24. Ansari G., Mojtahedzadeh M., Kajbaf F., Najafi A., Khajavi, Khalili H., et al., How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines, Adv. Ther., 2008, 25, 1-22.
25. Ansari G., Mojtahedzadeh M., Kajbaf F., Najafi A., Khajavi M. R., Khalili H., et al., How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines, Adv. Ther., 2008, 25, 681-702.
26. Mojtahedzadeh M., Rouini M. R., Kajbaf F., Najafi A., Ansari G., Gholipour A., et al., Advantage of adjunct metformin and insulin therapy in the management of glycemia in critically ill patients. evidence for nonoccurrence of lactic acidosis and needing to parenteral metformin, Arch. Med. Sci., 2008, 4, 174-181.
27. Egan B. M., Greene E. L., Goodfriend T. L., Insulin resistance and cardiovascular disease, Am. J. Hypertens., 2001, 14, 116S-125S.
28. Haak E., Usadel K. H., Kusterer K., Amini P., Frommeyer R., Tritschler H. J., et al., Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy, Exp. Clin. Endocrinol. Diabetes., 2000, 108, 168-174.
29. Nazirogilu M., Butterworth P., Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes, Can. J. Appl. Physiol., 2005, 30, 172-185.
30. Kowluru R. A., Kennedy A., Therapeutic potential of anti-oxidants and diabetic retinopathy, Expert Opin. Investig. Drugs, 2001, 10, 1665-1676.
31. Silva B. M., Andrade P. B., Valentao P., Ferreres F., Seabra R. M., Ferreira M. A., Quince (Cydonia oblonga Miller) fruit (pulp, peel, and seed) and jam: antioxidant activity, J. Agric. Food Chem., 2004, 52, 4705-4712.
32. Wichtl M., Anton R., Plantes therapeutiques, Tech. & Doc., Paris, 1999, 291-293, (in French).
33. Solar A., Colaric M., Usenik V., Stampar F., Seasonal variation of selected flavonoids, phenolic acids and quinones in annual shorts of common walnut (Juglans regia L.), Plant Sci., 2006, 170, 461-543.
34. Anderson K. J., Teuber S. S., Gobeille A., Cremin P., Waterhouse A. L., Steinberg F. M., Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation, J. Nutr., 2001, 131, 2837-2842.
35. Fukuda T., Ito H., Yoshida T., Antioxidative polyphenols from walnuts (Juglans regia L.), Phytochemistry, 2003, 63, 795-801.
36. Tieppo J., Vercelino R., Dias A. S., Silva Vaz M. F., Silveira T. R., Marroni C. A., et al., Evaluation of the protective effects of quercetin in the hepatopulmonary Syndrome, Food Chem. Toxicol., 2007, 45, 1140-1146.
37. Wilms L. C., Hollman P. C., Boots A. W., Kleinjans J. C., Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes, Mutat. Res., 2005, 582, 155-162.
38. Laranjinha J. A., Almeida L. M., Madeira V. M., Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation, Biochem. Pharmacol., 1994, 48, 487-494.
39. Liu R. H., Health benefits of fruits and vegetables are from additive and synergistic combination of phytochemicals, Am. J. Clin. Nutr., 2003, 78, 517S-520S.
40. Nus M., Ruperto M., Sánchez-Muniz F. J., Nuts, cardio and cerebrovascular risks. A Spanish perspective, Arch. Latinoam. Nutr., 2004, 54, 137-148.
41. Kris-Etherton P. M., Yu-Poth S., Sabaté J., Ratcliffe H. E., Zhao G., Etherton T. D., Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk, Am. J. Clin. Nutr., 1999, 70, 504S-511S.
42. Tapsell L. C., Gillen L. J., Patch C. S., Batterham M., Owen A., Baré M., et al., Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes, Diabetes Care, 2004, 27, 2777-2783.
43. Radfar M., Larijani B., Hadjibabaie M., Rajabipour B., Mojtahedi A., Abdollahi M., Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; A randomized, double-blind placebo-controlled clinical trial, Biomed. Pharmacother., 2005, 59, 302-306.
44. Astaneie F., Afshari M., Mojtahedi A., Mostafalou S., Zamani M. J., Larijani B., et al., Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients, Arch. Med. Res., 2005, 36, 376-381.
45. Milani E., Nikfar S., Khorasani R., Zamani M. J., Abdollahi M., Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats, Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol., 2005, 140, 251-255.